These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 17403066)

  • 1. Impact of hepatitis C on HIV progression in adults with alcohol problems.
    Cheng DM; Nunes D; Libman H; Vidaver J; Alperen JK; Saitz R; Samet JH
    Alcohol Clin Exp Res; 2007 May; 31(5):829-36. PubMed ID: 17403066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers to treatment of hepatitis C in HIV/HCV-coinfected adults with alcohol problems.
    Nunes D; Saitz R; Libman H; Cheng DM; Vidaver J; Samet JH
    Alcohol Clin Exp Res; 2006 Sep; 30(9):1520-6. PubMed ID: 16930214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival.
    Chen M; Wong WW; Law MG; Kiertiburanakul S; Yunihastuti E; Merati TP; Lim PL; Chaiwarith R; Phanuphak P; Lee MP; Kumarasamy N; Saphonn V; Ditangco R; Sim BL; Nguyen KV; Pujari S; Kamarulzaman A; Zhang F; Pham TT; Choi JY; Oka S; Kantipong P; Mustafa M; Ratanasuwan W; Durier N; Chen YM
    PLoS One; 2016; 11(3):e0150512. PubMed ID: 26933963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy.
    Potter M; Odueyungbo A; Yang H; Saeed S; Klein MB;
    AIDS; 2010 Jul; 24(12):1857-65. PubMed ID: 20479633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of alcohol use and highly active antiretroviral therapy on plasma levels of hepatitis C virus (HCV) in patients coinfected with HIV and HCV.
    Cooper CL; Cameron DW
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S105-9. PubMed ID: 16265607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between hepatitis C virus (HCV) and insulin resistance, endothelial perturbation, and platelet activation in HIV-HCV-coinfected patients under highly active antiretroviral treatment.
    de Larrañaga GF; Wingeyer SD; Puga LM; Alonso BS; Benetucci JA
    Eur J Clin Microbiol Infect Dis; 2006 Feb; 25(2):98-103. PubMed ID: 16477441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study.
    Hershow RC; O'Driscoll PT; Handelsman E; Pitt J; Hillyer G; Serchuck L; Lu M; Chen KT; Yawetz S; Pacheco S; Davenny K; Adeniyi-Jones S; Thomas DL
    Clin Infect Dis; 2005 Mar; 40(6):859-67. PubMed ID: 15736020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
    Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT
    AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.
    Rockstroh JK; Mocroft A; Soriano V; Tural C; Losso MH; Horban A; Kirk O; Phillips A; Ledergerber B; Lundgren J;
    J Infect Dis; 2005 Sep; 192(6):992-1002. PubMed ID: 16107951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study.
    Focà E; Fabbiani M; Prosperi M; Quiros Roldan E; Castelli F; Maggiolo F; Di Filippo E; Di Giambenedetto S; Gagliardini R; Saracino A; Di Pietro M; Gori A; Sighinolfi L; Pan A; Postorino MC; Torti C;
    Medicine (Baltimore); 2016 Jul; 95(29):e4091. PubMed ID: 27442636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of IL-2 on hepatitis C virus RNA levels in patients co-infected with human immunodeficiency virus receiving HAART.
    Tedaldi EM; Chen L; Markowitz N; Kelly L; Abrams D;
    J Viral Hepat; 2005 Jul; 12(4):414-20. PubMed ID: 15985013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low current and nadir CD4+ T-cell counts are associated with higher hepatitis C virus RNA levels in the Swiss HIV cohort study.
    Rauch A; Gaudieri S; Evison J; Nolan D; Cavassini M; Weber R; James I; Furrer H;
    Antivir Ther; 2008; 13(3):455-60. PubMed ID: 18572759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic response to antiretroviral therapy in hepatitis C virus-coinfected adults in a population-based HIV/AIDS treatment program.
    Braitstein P; Zala C; Yip B; Brinkhof MW; Moore D; Hogg RS; Montaner JS
    J Infect Dis; 2006 Jan; 193(2):259-68. PubMed ID: 16362890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of incident hepatitis C infection on CD4+ cell count and HIV RNA trajectories based on a multinational HIV seroconversion cohort.
    van Santen DK; van der Helm JJ; Touloumi G; Pantazis N; Muga R; Gunsenheimer-Bartmeyer B; Gill MJ; Sanders E; Kelleher A; Zangerle R; Porter K; Prins M; Geskus RB;
    AIDS; 2019 Feb; 33(2):327-337. PubMed ID: 30325767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype.
    Schwarze-Zander C; Blackard JT; Zheng H; Addo MM; Lin W; Robbins GK; Sherman KE; Zdunek D; Hess G; Chung RT;
    J Infect Dis; 2006 Aug; 194(4):410-9. PubMed ID: 16845623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients.
    Mohsen AH; Easterbrook PJ; Taylor C; Portmann B; Kulasegaram R; Murad S; Wiselka M; Norris S
    Gut; 2003 Jul; 52(7):1035-40. PubMed ID: 12801963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of chronic hepatitis C on HIV-1 disease progression.
    Carlos Martín J; Castilla J; López M; Arranz R; González-Lahoz J; Soriano V
    HIV Clin Trials; 2004; 5(3):125-31. PubMed ID: 15248136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: a nationwide cohort study.
    Weis N; Lindhardt BO; Kronborg G; Hansen AB; Laursen AL; Christensen PB; Nielsen H; Moller A; Sorensen HT; Obel N
    Clin Infect Dis; 2006 May; 42(10):1481-7. PubMed ID: 16619163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
    Roux P; Fugon L; Winnock M; Salmon-Céron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP;
    Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.